• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Erratum: Clinical Implications of Minimal Residual Disease Detection in Infants With -Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol.

出版信息

J Clin Oncol. 2023 Oct 20;41(30):4825. doi: 10.1200/JCO.23.01844. Epub 2023 Sep 12.

DOI:10.1200/JCO.23.01844
PMID:37699172
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11556796/
Abstract
摘要

相似文献

1
Erratum: Clinical Implications of Minimal Residual Disease Detection in Infants With -Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol.勘误：在Interfant-06方案治疗的伴有重排的急性淋巴细胞白血病婴儿中检测微小残留病的临床意义。
J Clin Oncol. 2023 Oct 20;41(30):4825. doi: 10.1200/JCO.23.01844. Epub 2023 Sep 12.
2
Clinical Implications of Minimal Residual Disease Detection in Infants With -Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol.《基于 Interfant-06 方案治疗伴有 - 重现性急性淋巴细胞白血病婴儿患者中微小残留病灶检测的临床意义》。
J Clin Oncol. 2021 Feb 20;39(6):652-662. doi: 10.1200/JCO.20.02333. Epub 2021 Jan 6.
3
Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol.采用Interfant-06方案治疗的婴儿KMT2A胚系急性淋巴细胞白血病的微小残留病及预后特征
Eur J Cancer. 2022 Jan;160:72-79. doi: 10.1016/j.ejca.2021.10.004. Epub 2021 Nov 13.
4
Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia.Blinatumomab 联合化疗治疗婴儿急性淋巴细胞白血病。
N Engl J Med. 2023 Apr 27;388(17):1572-1581. doi: 10.1056/NEJMoa2214171.
5
Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631.微小残留病可预测KMT2A重排而非KMT2A胚系突变的婴儿急性淋巴细胞白血病的预后：儿童肿瘤学组AALL0631研究报告
Pediatr Blood Cancer. 2023 May 31:e30467. doi: 10.1002/pbc.30467.
6
Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study.《国际多中心 III 期随机研究：婴儿急性淋巴细胞白血病采用 Interfant-06 方案治疗的结局》
J Clin Oncol. 2019 Sep 1;37(25):2246-2256. doi: 10.1200/JCO.19.00261. Epub 2019 Jul 8.
7
No benefit of Interfant protocols compared to BFM-based protocols for infants with acute lymphoblastic leukemia. Results from an institution in Argentina.与基于 BFM 方案相比，Interfant 方案对急性淋巴细胞白血病婴儿无益。来自阿根廷一家机构的结果。
Pediatr Blood Cancer. 2020 Oct;67(10):e28624. doi: 10.1002/pbc.28624. Epub 2020 Jul 30.
8
Hematopoietic stem cell transplantation for infants with high-risk KMT2A gene-rearranged acute lymphoblastic leukemia.高危KMT2A基因重排急性淋巴细胞白血病婴儿的造血干细胞移植
Blood Adv. 2021 Oct 12;5(19):3891-3899. doi: 10.1182/bloodadvances.2020004157.
9
Genetic characteristics and treatment outcome in infants with KMT2A germline B-cell precursor acute lymphoblastic leukemia: Results of MLL-Baby protocol.KMT2A种系B细胞前体急性淋巴细胞白血病婴儿的遗传特征与治疗结果：MLL-Baby方案的结果
Pediatr Blood Cancer. 2023 Apr;70(4):e30204. doi: 10.1002/pbc.30204. Epub 2023 Jan 30.
10
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol.采用Interfant-99方案治疗的急性淋巴细胞白血病婴儿微小残留病的预后意义
Leukemia. 2009 Jun;23(6):1073-9. doi: 10.1038/leu.2009.17. Epub 2009 Feb 12.